The second Ambulatory Glucose Profiling (AGP) and Digital Therapeutics (DTx) conference recently took place in Shenzhen, China, bringing together healthcare experts from around the world to discuss the application of AGP in diabetes diagnosis and treatment. Led by the National Innovation Center for Advanced Medical Devices and sponsored by the China AGP and DTx Digital Therapeutics R&D Center, the conference addressed critical topics such as AGP consensus, artificial pancreas system, and digital health management.
One of the key speakers at the event, Professor Andrej Janež from the University of Lublin Medical Center in Slovenia, praised China’s progress in AGP clinical practice. He noted that China has developed an AGP training program and is utilizing AI to enhance diagnosis and treatment decisions, ultimately improving diabetes care and facilitating AGP applications on a global scale.
To further advance diabetes diagnosis and treatment innovation, the AGP&DTx International R&D Consortium was established at the forum. This consortium aims to standardize AGP clinical applications worldwide and provide a platform for international collaboration and knowledge sharing in the field of diabetes management.
SIBIONICS, a company dedicated to the research and development of implantable medical devices, has been at the forefront of personalized diabetes management solutions since its founding in 2015. With over 1,000,000 users globally, SIBIONICS is committed to pushing the boundaries of CGM technology and patient-centric designs to revolutionize diabetes care.
The conference attendees, including experts from Slovenia, Australia, Saudi Arabia, and other countries, explored the latest advancements in diabetes management technology and its practical applications in clinical settings. By gathering insights from various regions and disciplines, the summit forum aimed to foster collaboration and knowledge exchange to elevate diabetes diagnosis and treatment on a global scale.
Overall, the AGP&DTx Summit Forum in Shenzhen served as a hub for international experts to share their insights and experiences in the field of diabetes management. With a focus on innovation, collaboration, and standardization, the event laid the foundation for future advancements in precision diagnosis and treatment of diabetes through the use of AGP and digital therapeutics.
Source link
